A detailed history of Tekla Capital Management LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Tekla Capital Management LLC holds 87,840 shares of IONS stock, worth $3.31 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
87,840
Previous 87,840 -0.0%
Holding current value
$3.31 Million
Previous $3.14 Million 14.81%
% of portfolio
0.14%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

SELL
$36.54 - $48.66 $3.21 Million - $4.27 Million
-87,840 Reduced 50.0%
87,840 $3.89 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $3.76 Million - $5.15 Million
-146,841 Reduced 45.53%
175,680 $5.35 Million
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $3.67 Million - $5.02 Million
106,150 Added 49.06%
322,521 $12.9 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $984,956 - $1.48 Million
23,170 Added 11.99%
216,371 $9.73 Million
Q1 2020

May 14, 2020

SELL
$41.6 - $63.4 $695,676 - $1.06 Million
-16,723 Reduced 7.97%
193,201 $9.14 Million
Q4 2019

Feb 13, 2020

BUY
$53.85 - $65.27 $1.28 Million - $1.55 Million
23,680 Added 12.71%
209,924 $12.7 Million
Q3 2019

Nov 13, 2019

BUY
$59.06 - $72.15 $3.46 Million - $4.23 Million
58,646 Added 45.96%
186,244 $11.2 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $1.11 Million - $1.54 Million
17,878 Added 16.29%
127,598 $8.2 Million
Q1 2019

May 14, 2019

BUY
$52.92 - $81.17 $1.42 Million - $2.18 Million
26,882 Added 32.45%
109,720 $8.91 Million
Q2 2018

Aug 13, 2018

SELL
$40.53 - $50.7 $3.36 Million - $4.2 Million
-82,839 Reduced 50.0%
82,838 $3.45 Million
Q1 2018

May 14, 2018

BUY
$44.08 - $55.05 $1.62 Million - $2.02 Million
36,747 Added 28.5%
165,677 $7.3 Million
Q4 2017

Feb 14, 2018

BUY
$50.3 - $64.39 $6.49 Million - $8.3 Million
128,930
128,930 $6.49 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.